0 0.5 1 1.5+ All studies 43% 7 875 Improvement, Studies, Patients Relative Risk Mortality 77% 3 550 Ventilation 89% 1 78 ICU admission 82% 1 78 Hospitalization 10% 4 679 Viral clearance -24% 3 321 RCTs 43% 7 875 RCT mortality 77% 3 550 Peer-reviewed 54% 6 503 Prophylaxis 65% 2 422 Early 84% 2 269 Late 44% 3 184 Bromhexine for COVID-19 c19early.org October 2023 Favorsbromhexine Favorscontrol